Coverage and Payment of Beyfortus® (nirsevimab)
Customize your policy alerts
Sign up for all Ohio Department of Medicaid policy alerts
Know when Ohio Department of Medicaid releases new policies or updates existing guidance.
Monitor payer policy activity
This directive governs Medicaid managed care plan coverage, prior authorization, and payment treatment for Beyfortus used to prevent RSV in infants. Plans may remove coverage for the drug product because it can be obtained through the Vaccines for Children Program, but must continue covering its administration component.
Plans may remove coverage for Beyfortus because the product can be sourced through the Vaccines for Children Program.
Plans remain required to cover the administration component for Beyfortus.
The prior direction to align MCO coverage with Fee-for-Service coverage without prior authorization for medical claims using CPT 90380 and 90381 is superseded by updated product-coverage direction.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.